ICC Capital Management’s Gilead Sciences GILD Stock Holding History

ICC Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2.74M	Sell	27,965 -1,590	-5%	-$161K	0.36%	104
2014 Q4	$2.79M	Sell	29,555 -810	-3%	-$83.8K	0.36%	104
2014 Q3	$3.23M	Buy	30,365 +2,170	+8%	+$212K	0.39%	100
2014 Q2	$2.34M	Buy	28,195 +11,995	+74%	+$934K	0.25%	126
2014 Q1	$1.15M	Buy	+16,200	New	+$1.27M	0.1%	168
2013 Q3	–	Sell	-1,654	Closed	-$85K	–	237
2013 Q2	$85K	Buy	+1,654	New	+$86.2K	0.01%	204

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

ICC Capital Management's GILD Position: Q1 2015 in Review

ICC Capital Management reduced its Gilead Sciences (GILD) stake by 5.4% in Q1 2015, selling an estimated $161K and leaving 27,965 shares worth $2.74M. The position accounts for 0.36% of the portfolio, ranked #104.

ICC Capital Management first reported a position in GILD in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.23M in Q3 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

ICC Capital Management held 27,965 shares of Gilead Sciences worth $2.74M as of Q1 2015.
ICC Capital Management sold 1,590 Gilead Sciences shares in Q1 2015, an estimated $161K.
Gilead Sciences made up 0.36% of ICC Capital Management's portfolio in Q1 2015, its #104 holding.
ICC Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 6 quarters since.
ICC Capital Management's Gilead Sciences position peaked at $3.23M in Q3 2014.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on ICC Capital Management's 13F filing for Q1 2015, filed 13 May 2015.